Global Clinical Trials in India 3
                     Global Clinical Trials in India: 
Understanding Regulatory and 
Operational Requirements
Planning global clinical trials in India requires sponsors to understand both 
regulatory expectations and practical study execution. While India offers 
significant opportunities for multinational research, successful implementation 
depends on detailed preparation.
Understanding the Indian Regulatory Landscape
India has established a structured regulatory framework for clinical research. 
CDSCO plays an important role in overseeing clinical trials and new drug 
development.
The New Drugs and Clinical Trials Rules, 2019, provide provisions related to 
clinical trials, ethics committees, safety monitoring, and regulatory 
requirements.
Sponsors should determine the applicable regulatory pathway before initiating 
activities in India.
Ethics Committee Requirements
Ethical oversight is an important part of clinical research. Clinical trial sites must 
work with appropriately registered Ethics Committees for review and approval of 
study-related activities.
Participant rights, informed consent, safety, confidentiality, and ethical conduct 
remain central considerations.
Site Feasibility
Site selection can determine whether a clinical trial achieves its recruitment 
and quality objectives.
Sponsors should evaluate:
● Investigator qualifications
● Patient availability
● Previous trial experience
● Site infrastructure
● Staffing
● Laboratory capabilities
● Recruitment history
● Competing studies
A strong feasibility assessment helps identify sites capable of delivering the 
protocol effectively.
Patient Recruitment
India's diverse population provides access to patients across numerous 
therapeutic areas. However, recruitment should be evaluated on a site-by-site 
basis.
Factors such as referral patterns, disease prevalence, treatment pathways, 
and patient willingness to participate can influence enrollment.
Study Monitoring
Monitoring helps ensure that sites follow the protocol and maintain appropriate 
documentation. Regular oversight can identify issues involving data quality, 
informed consent, safety reporting, and protocol compliance.
For multinational studies, monitoring should also ensure that Indian sites remain 
aligned with global study expectations.
Data Quality
Clinical data generated in India may contribute to international regulatory 
submissions. Therefore, data quality and consistency are essential.
Electronic data capture, source documentation, query management, medical 
coding, and database processes should be implemented according to the 
study plan.
Safety Reporting
Safety monitoring is another critical component. Serious adverse events and other 
reportable safety information must be handled according to applicable requirements 
and study procedures.
Clear communication between investigators, sponsors, CROs, and safety teams 
helps maintain timely reporting.
Global clinical trials in India require a balanced approach combining regulatory 
knowledge, site feasibility, patient recruitment planning, quality oversight, and 
operational coordination.
When these factors are addressed early, India can contribute effectively to 
multinational clinical development programs.